Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/19405
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBaker, Jenalle E-
dc.contributor.authorYing Lim, Yen-
dc.contributor.authorJaeger, Judith-
dc.contributor.authorAmes, David-
dc.contributor.authorLautenschlager, Nicola T-
dc.contributor.authorRobertson, Joanne-
dc.contributor.authorPietrzak, Robert H-
dc.contributor.authorSnyder, Peter J-
dc.contributor.authorVillemagne, Victor L-
dc.contributor.authorRowe, Christopher C-
dc.contributor.authorMasters, Colin L-
dc.contributor.authorMaruff, Paul-
dc.date2018-
dc.date.accessioned2018-09-17T01:47:05Z-
dc.date.available2018-09-17T01:47:05Z-
dc.date.issued2018-08-09-
dc.identifier.citationJournal of Alzheimer's disease : JAD 2018; 65(3): 977-988en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/19405-
dc.description.abstractRecent meta-analyses suggest that episodic memory impairment associated with preclinical Alzheimer's disease (AD) equates to 0.15-0.24 standard deviations below that of cognitively healthy older adults. The current study aimed to characterize impairments in verbal acquisition and recall detectable at a single assessment, and investigate how verbal learning and episodic memory deteriorates in preclinical AD. A verbal list-learning task, the International Shopping List Test (ISLT), was administered multiple times over an 18-month period, to three groups of participants: amyloid-beta negative healthy older adults (Aβ- CN; n = 50); Aβ+ positive healthy older adults (preclinical AD; n = 25); and Aβ+ positive individuals diagnosed with mild cognitive impairment (prodromal AD; n = 22). At baseline, there was no significant difference between the preclinical AD and control groups rate of acquisition, or total and delayed recall, however all indices were impaired in prodromal AD. Performance on ISLT total score improved in the control group over the 18-month period, but showed a moderate magnitude decline in the preclinical AD group (Cohen's d = - 0.63, [- 1.12, - 0.14]) and the prodromal AD group (Cohen's d = - 0.36, [- 0.94, 0.22]). No significant impairment in acquisition associated with preclinical AD was seen at baseline. Individuals with preclinical AD showed a significantly different performance on the ISLT total score over an 18-month period, compared to those without abnormal Aβ. Individuals with prodromal AD showed substantial impairment on the ISLT at baseline and declined to a greater extent over time.en
dc.language.isoeng-
dc.subjectAlzheimer’s diseaseen
dc.subjectamyloid-β proteinen
dc.subjectcognitive declineen
dc.subjectlearning curveen
dc.subjectmemory and learning testsen
dc.subjectmild cognitive impairmenten
dc.subjectneuropsychologyen
dc.subjecttransfer of learningen
dc.titleEpisodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Alzheimer's disease : JADen
dc.identifier.affiliationCogstate Ltd., Melbourne, Victoria, Australiaen
dc.identifier.affiliationRyan Institute for Neuroscience, University of Rhode Island, Kingston, RI, USAen
dc.identifier.affiliationDepartment of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australiaen
dc.identifier.affiliationCooperative Research Centre for Mental Health, Carlton, Victoria, Australiaen
dc.identifier.affiliationCognitionMetrics, LLC., Wilmington, DE, USAen
dc.identifier.affiliationAlbert Einstein College of Medicine, Bronx, NY, USAen
dc.identifier.affiliationNational Ageing Research Institute, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Psychiatry, Academic Unit for Psychiatry of Old Age, The University of Melbourne, St. George's Hospital, Kew, Victoria, Australiaen
dc.identifier.affiliationU.S. Department of Veterans Affairs National Center for Posttraumatic Stress Disorder, Clinical Neurosciences Division, VA Connecticut Healthcare System, West Haven, CT, USAen
dc.identifier.affiliationDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USAen
dc.identifier.doi10.3233/JAD-180344en
dc.type.contentTexten
dc.identifier.orcid0000-0003-3910-2453en
dc.identifier.pubmedid30103330-
dc.type.austinJournal Article-
local.name.researcherMasters, Colin L
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

54
checked on Nov 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.